HRMY

Harmony Biosciences Holdings, Inc. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website armonybiosciences.com
Employees(FY) 200
ISIN US4131971040

Performance

+2.21%

+14.06%

+14.94%

+14.7%

+12.9%

YTD

+23.18%

Profile

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. It offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.

Advanced Technical Analysis

Technical Analysis of HRMY 2025-01-31

The stock exhibits a strong bullish sentiment with a Moving Average Score of 83 and a Technical Score of 78, indicating positive momentum and trend strength. However, the Oscillators Score of 46 suggests a neutral stance, implying potential caution in the short term despite the overall bullish outlook.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of HRMY

Stock Rank

Recent News & Updates

2025-01-31 09:55
Wall Street Analysts Predict a 28.98% Upside in Harmony Biosciences (HRMY): Here's What You Should Know(Zacks)
2025-01-30 15:32
Harmony Biosciences Stock Scores 80-Plus RS Rating(Investor's Business Daily)
2025-01-30 11:40
HRMY vs. RGEN: Which Stock Is the Better Value Option?(Zacks)
2025-01-28 19:00
HRMY: Lowering target price to $40.00(Argus Research)
2025-01-28 16:11
Harmony Biosciences Holdings Insider Sold Shares Worth $551,575, According to a Recent SEC Filing(MT Newswires)
2025-01-25 07:25
Is Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Recent Stock Performance Tethered To Its Strong Fundamentals?(Simply Wall St.)
2025-01-24 01:20
Zacks.com featured highlights include Harmony Biosciences, Ingevity, Gulfport Energy and Pitney Bowes(Zacks)
2025-01-23 16:21
Harmony Biosciences Holdings Insider Sold Shares Worth $774,245, According to a Recent SEC Filing(MT Newswires)
2025-01-23 07:26
4 High Earnings Yield Value Stocks to Buy as Trump Resumes Presidency(Zacks)
2025-01-21 19:00
HRMY: Raising target price to $42.00(Argus Research)
2025-01-20 09:40
Should Value Investors Buy Harmony Biosciences (HRMY) Stock?(Zacks)
2025-01-15 12:20
Why Harmony Biosciences (HRMY) Might be Well Poised for a Surge(Zacks)
2025-01-15 09:55
How Much Upside is Left in Harmony Biosciences (HRMY)? Wall Street Analysts Think 39.48%(Zacks)
2025-01-14 19:11
Harmony Biosciences price target raised to $32 from $31 at BofA(Yahoo Finance)
2025-01-14 19:00
HRMY: Raising target price to $38.00(Argus Research)
2025-01-14 11:40
HRMY or RGEN: Which Is the Better Value Stock Right Now?(Zacks)
2025-01-14 09:40
Are Investors Undervaluing Genmab (GMAB) Right Now?(Zacks)
2025-01-13 16:15
Why Harmony Biosciences (HRMY) Is the Top Small Cap Stock to Buy with the Highest Upside Potential(Insider Monkey)
2025-01-13 16:15
BridgeBio, ARS Pharma, Harmony Bio Shine At JPM. But SpringWorks, Beam Take Their Lumps.(Investor's Business Daily)
2025-01-13 09:01
Harmony Biosciences Reports Preliminary Q4, 2024 Net Product Revenue; 2025 Revenue Guidance Issued(MT Newswires)
2025-01-13 08:05
Harmony Biosciences Reports Strong 2024 Revenues, Provides 2025 Revenue Guidance and Highlights Key Pipeline Catalysts(Business Wire)
2025-01-12 19:05
Harmony Biosciences Reports Strong 2024 Revenues, Provides 2025 Revenue Guidance and Highlights Key Pipeline Catalysts(Businesswire)
2025-01-12 19:05
Harmony Biosciences Reports Strong 2024 Revenues, Provides 2025 Revenue Guidance and Highlights Key Pipeline Catalysts(Businesswire)
2025-01-07 19:00
HRMY: Raising target price to $37.00(Argus Research)
2024-12-30 19:00
HRMY: Lowering target price to $36.00(Argus Research)
2024-12-23 19:00
HRMY: Raising target price to $37.00(Argus Research)
2024-12-18 08:05
HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE(PR Newswire)
2024-12-17 19:05
HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE(Prnewswire)
2024-12-17 19:00
HRMY: Raising target price to $35.00(Argus Research)
2024-12-17 08:37
HC Wainwright Initiates Harmony Biosciences at Buy With $75 Price Target(MT Newswires)

Page 1 of 10

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.